Suggest an ACEI or an ARB for Hypertension or Diabetic Kidney Disease

March 2016

A shift in thinking about the CV benefits of ARBs will lead to more use of ARBs instead of ACE inhibitors.

We're used to recommending ACEIs...since they have more CV outcomes data and SEEMED to have a bigger impact on CV events than ARBs.

And low-cost generic ACEIs have been available for years.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote